Expert validation of an artificial intelligence–enabled trial matching solution using real-world data from patients with cancer. Predicted vs. reported HR of each trial.
Predictive biomarkers to guide selection of first-line chemotherapy for advanced pancreatic ductal adenocarcinoma (PDAC) are an unmet clinical need. This study used the Computational Histology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results